
Genentech wins FDA approval of drug to treat two blinding eye diseases
The drug, which will cost $2,190 per dose when sales begin in the coming weeks, ultimately can be dosed every one to four months.
The drug, which will cost $2,190 per dose when sales begin in the coming weeks, ultimately can be dosed every one to four months.
PEORIA, Ill. and OAKLAND, Calif.: PEORIA, Ill. and OAKLAND, Calif., Jan. 31, 2022 /PRNewswire/ — Elemeno Health, the developer of a proprietary cloud-based solution for frontline health care teams, and OSF HealthCare, one of the largest health systems… […]
The new company’s approach, which is expected to enter an early-stage clinical trial this year, could both activate and suppress the immune system’s response to solid tumors.
LAS VEGAS: LAS VEGAS, Jan. 31, 2022 /PRNewswire/ — DelveInsight’s Food Allergy Market Insights report proffers a detailed comprehension of Food Allergy market size by treatment, epidemiology, emerging therapies, Food Allergy market share of the indivi… […]
SAN FRANCISCO: SAN FRANCISCO, Jan. 31, 2022 /PRNewswire/ — InsightRX, a healthcare technology company that provides precision dosing intelligence from clinical development to the point of care, announced a year of record growth in clinician users, act… […]
CHICAGO: CHICAGO, Jan. 31, 2022 /PRNewswire/ — The Illinois Biotechnology Innovation Organization (iBIO), dedicated to inspiring the next generation of innovators and helping restore America’s leadership in technology education, today announced they w… […]
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea
kdunleavy
Mon, 01/31/2022 – 09:52
[…]
FREMONT, Calif.: FREMONT, Calif., Jan.31, 2022 /PRNewswire-PRWeb/ –Power Knot LLC, the market leader for onsite organic waste management solutions, announced today that Dubai Creative Group and Power Knot have collaborated with Microsoft Dubai to crea… […]
OAKLAND, N.J.: OAKLAND, N.J., Jan. 31, 2022 /PRNewswire/ — Collagen Matrix Inc., a leader in regenerative medicine, global manufacturer of collagen and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the a… […]
SAN FRANCISCO–(BUSINESS WIRE)–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that its Acoustic Enhancer technology has received Breakthrough Device designation from the U.S. Food and Drug Admini… […]
Copyright © 2022 Biotech Networks, LLC